CAS: 102919-85-7 - (5α,6α)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)morphinan-3,14-diol
Formula:C21H28N2O3
InChI:InChI=1S/C21H28N2O3/c1-22-14-6-7-21(25)16-10-13-4-5-15(24)18-17(13)20(21,19(14)26-18)8-9-23(16)11-12-2-3-12/h4-5,12,14,16,19,22,24-25H,2-3,6-11H2,1H3/t14-,16+,19-,20-,21+/m0/s1
InChI key:InChIKey=MDPFGNLTFZJSEZ-LAKPAKELSA-N
SMILES:OC1=CC=C2C3=C1OC4C(NC)CCC5(O)C(N(CCC345)CC6CC6)C2
- Synonyms:
- (5α,6α)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)morphinan-3,14-diol
- (5a,6a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-morphinan-3,14-diol
- Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-, (5α,6α)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
(5α,6α)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-morphinan-3,14-diol REF: TR-C988730CAS: 102919-85-7 | - - - | 135.00 €~513.00 € | Tue 21 Jan 25 | |
(5a,6a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-morphinan-3,14-diol REF: 3D-FC20743CAS: 102919-85-7 | Min. 95% | - - - | Discontinued product |
(5α,6α)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-morphinan-3,14-diol
Controlled ProductCAS:102919-85-7
Applications Opioid receptor antagonist. References Mohamed, M.S. et al.: J. Med. Chem. 29, 1551 (1986).
Formula:
C21H28N2O3
Color and Shape:
Neat
Molecular weight:
356.46
Ref: TR-C988730
10mg | 135.00 € | ||
25mg | 284.00 € | ||
50mg | 513.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(5a,6a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-morphinan-3,14-diol
CAS:102919-85-7
Please enquire for more information about (5a,6a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-morphinan-3,14-diol including the price, delivery time and more detailed …
Formula:
C21H28N2O3
Purity:
Min. 95%
Molecular weight:
356.46 g/mol
Ref: 3D-FC20743
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |